|
CATX Perspective Therapeutics Inc 728387 |
| Balance Sheet |
|
Current Assets
|
$241,523,000.00 |
|
Assets
|
$392,025,000.00 |
|
Current Liabilities
|
$36,544,000.00 |
|
Liabilities
|
$68,162,000.00 |
|
Equity
|
$323,863,000.00 |
|
Shares Out
|
114086092.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-52,118,000.00 |
|
Investing Cash Flow
|
$-94,534,000.00 |
| Market Analysis |
Market Cap
|
$366,216,355.32 |
|
Price
|
$2.88 |
|
BVPS
|
2.84 |
|
PB
|
1.13 |
|
EPS
|
-0.22 |
|
PS
|
255.38 |
|
FCF
|
$-73,171,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:42 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:33 |
|
| Apr |
May |
Jun |
| 2026-03-16 |
-1.40 |
|
|
2026-05-11 |
-0.25 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.29 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.35 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CATX documents filed with the SEC.
CATX Filings
Clear
